Uploaded February 2024 | Updated September 2026, 1 day ago

---

For people with obesity, new medications like Ozempic and Wegovy—brand names for the anti-obesity drug semaglutide—have been game-changers. They’ve become so popular, in fact, that the companies that make these drugs have been unable to keep up with demand.

Robert Kushner, MD, helped show the effectiveness of new anti-obesity medications that also help reduce cardiovascular disease risk.

Read the full story: spr.ly/6005VjsLR

------------------------------------------

Visit the Feinberg website: https://www.feinberg.northwestern.edu/

SUBSCRIBE: spr.ly/60073dxlv

TWITTER (X): spr.ly/60003dxmj
INSTAGRAM: spr.ly/60083dxWi
FACEBOOK: spr.ly/60063dxW0
LINKEDIN: spr.ly/60063dxqG

About Northwestern University Feinberg School of Medicine:

Our mission is to impact the practice of medicine through discovery and education to improve human health.